Compare AZN & INTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AZN | INTC |
|---|---|---|
| Founded | 1992 | 1968 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.7B | 252.7B |
| IPO Year | N/A | N/A |
| Metric | AZN | INTC |
|---|---|---|
| Price | $208.86 | $45.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 33 |
| Target Price | N/A | ★ $43.13 |
| AVG Volume (30 Days) | 1.6M | ★ 126.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.84 | $3.89 |
| Revenue Next Year | $6.16 | $7.65 |
| P/E Ratio | $32.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $122.26 | $17.67 |
| 52 Week High | $212.19 | $54.60 |
| Indicator | AZN | INTC |
|---|---|---|
| Relative Strength Index (RSI) | 87.12 | 47.32 |
| Support Level | $187.06 | $44.97 |
| Resistance Level | $193.97 | $51.30 |
| Average True Range (ATR) | 4.23 | 2.91 |
| MACD | 4.29 | -0.69 |
| Stochastic Oscillator | 96.80 | 7.64 |
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
Intel is a leading digital chipmaker focused on designing and manufacturing microprocessors for the global personal computer and data center markets. Intel pioneered the x86 architecture for microprocessors and led the semiconductor industry down the path of Moore's law for advances in semiconductor manufacturing. Intel remains the market share leader in central processing units in both the PC and server end markets. The company is seeking to reinvigorate its chip manufacturing business, Intel Foundry, while developing leading-edge products in its Intel Products business segment.